Tiludronate Disodium

CHEMBL1200448 Phase 4 승인됨 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
362.6 g/mol
LogP
Phase
4

Tiludronate disodium is the disodium salt form of tiludronic acid, a second-generation bisphosphonate used for the treatment of Paget's disease of bone. See tiludronic-acid for complete pharmacological details. This salt formulation provides improved solubility for oral administration.

분자량

362.5700 g/mol

TPSA

146.00 Ų

치료 영역

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=P([O-])(O)C(Sc1ccc(Cl)cc1)P(=O)([O-])O.[Na+].[Na+]

InChI

InChI=1S/C7H9ClO6P2S.2Na/c8-5-1-3-6(4-2-5)17-7(15(9,10)11)16(12,13)14;;/h1-4,7H,(H2,9,10,11)(H2,12,13,14);;/q;2*+1/p-2

Molecular Formula

C7H7ClNa2O6P2S

HBD / HBA

2 / 7

회전 가능 결합

4

무거운 원자

19

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

Tiludronate disodium is the disodium salt form of tiludronic acid, a second-generation bisphosphonate used for the treatment of Paget's disease of bone. See tiludronic-acid for complete pharmacological details. This salt formulation provides improved solubility for oral administration.

Yes, Tiludronate Disodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200448. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 60936. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.